Skip to main content
Journal cover image

Testing a very low-carbohydrate adaption of the Diabetes Prevention Program among adults with prediabetes: study protocol for the Lifestyle Education about prediabetes (LEAP) trial.

Publication ,  Journal Article
Griauzde, DH; O'Brien, A; Yancy, WS; Richardson, CR; Krinock, J; DeJonckheere, M; Isaman, DJM; Vanias, K; Shopinski, S; Saslow, LR
Published in: Trials
September 30, 2022

BACKGROUND: The Center for Disease Control and Prevention's National Diabetes Prevention Program (NDPP) aims to help individuals with prediabetes avoid progression to type 2 diabetes mellitus (T2DM) through weight loss. Specifically, the NDPP teaches individuals to follow a low-fat, calorie-restricted diet and to engage in regular physical activity to achieve ≥ 5% body weight loss. Most NDPP participants, however, do not achieve this weight loss goal, and glycemic control remains largely unchanged. One promising opportunity to augment the NDPP's weight loss and glycemic effectiveness may be to teach participants to follow a very low-carbohydrate diet (VLCD), which can directly reduce post-prandial glycemia and facilitate weight loss by reducing circulating insulin and enabling lipolysis. To date, there have been no high-quality, randomized controlled trials to test whether a VLCD can prevent progression to T2DM among individuals with prediabetes. The aim of this study is to test the effectiveness of a VLCD version the NDPP (VLC-NDPP) versus the standard NDPP. We hypothesize the VLC-NDPP will demonstrate greater improvements in weight loss and glycemic control. METHODS: We propose to conduct a 12-month, 1:1, randomized controlled trial that will assign 300 adults with overweight or obesity and prediabetes to either the NDPP or VLC-NDPP. The primary outcome will be glycemic control as measured by change in hemoglobin A1c (HbA1c) from baseline to 12 months. Secondary outcomes will include percent body weight change and changes in glycemic variability, inflammatory markers, lipids, and interim HbA1c. We will evaluate progression to T2DM and initiation of anti-hyperglycemic agents. We will conduct qualitative interviews among a purposive sample of participants to explore barriers to and facilitators of dietary adherence. The principal quantitative analysis will be intent-to-treat using hierarchical linear mixed effects models to assess differences over time. DISCUSSION: The NDPP is the dominant public health strategy for T2DM prevention. Changing the program's dietary advice to include a carbohydrate-restricted eating pattern as an alternative option may enhance the program's effectiveness. If the VLC-NDPP shows promise, this trial would be a precursor to a multi-site trial with incident T2DM as the primary outcome. TRIAL REGISTRATION: NCT05235425. Registered February 11, 2022.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Trials

DOI

EISSN

1745-6215

Publication Date

September 30, 2022

Volume

23

Issue

1

Start / End Page

827

Location

England

Related Subject Headings

  • Weight Loss
  • Randomized Controlled Trials as Topic
  • Propiophenones
  • Prediabetic State
  • Nitro Compounds
  • Lipids
  • Life Style
  • Insulin
  • Hypoglycemic Agents
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Griauzde, D. H., O’Brien, A., Yancy, W. S., Richardson, C. R., Krinock, J., DeJonckheere, M., … Saslow, L. R. (2022). Testing a very low-carbohydrate adaption of the Diabetes Prevention Program among adults with prediabetes: study protocol for the Lifestyle Education about prediabetes (LEAP) trial. Trials, 23(1), 827. https://doi.org/10.1186/s13063-022-06770-3
Griauzde, Dina H., Alison O’Brien, William S. Yancy, Caroline R. Richardson, Jamie Krinock, Melissa DeJonckheere, Deanna J. M. Isaman, Kaitlyn Vanias, Samuel Shopinski, and Laura R. Saslow. “Testing a very low-carbohydrate adaption of the Diabetes Prevention Program among adults with prediabetes: study protocol for the Lifestyle Education about prediabetes (LEAP) trial.Trials 23, no. 1 (September 30, 2022): 827. https://doi.org/10.1186/s13063-022-06770-3.
Griauzde DH, O’Brien A, Yancy WS, Richardson CR, Krinock J, DeJonckheere M, Isaman DJM, Vanias K, Shopinski S, Saslow LR. Testing a very low-carbohydrate adaption of the Diabetes Prevention Program among adults with prediabetes: study protocol for the Lifestyle Education about prediabetes (LEAP) trial. Trials. 2022 Sep 30;23(1):827.
Journal cover image

Published In

Trials

DOI

EISSN

1745-6215

Publication Date

September 30, 2022

Volume

23

Issue

1

Start / End Page

827

Location

England

Related Subject Headings

  • Weight Loss
  • Randomized Controlled Trials as Topic
  • Propiophenones
  • Prediabetic State
  • Nitro Compounds
  • Lipids
  • Life Style
  • Insulin
  • Hypoglycemic Agents
  • Humans